Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1776111 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $63.96Day +6.49%Mkt cap $3.0B1Y +327.5%Off 52W high −4.1%Vol (1Y) 136.2%
Daily closing price, split-adjusted to the current basis; 1.8y shown of 459 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest12.1% of sh out |
| Days to cover6.2d |
| 13F net flow (QoQ)+5.05% |
| Top-10 13F concentration58.4% |
| Next report (est.)2026-08-04 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$86.6M |
| ROE−27.8% |
| ROIC−30.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+102.8% |
| 1Y+327.5% |
| Since incept. (ann.)+70.1% |
Total return through 2026-07-29 · series begins 2024-09-13. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)136.2% |
| Ann. volatility (3Y)118.0% |
| Sharpe (1Y)1.66 |
| Sharpe (3Y)0.96 |
| Max drawdown (1Y)−37.6% |
| Max drawdown (3Y)−77.7% |
| Beta (3Y vs SPY)0.04 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6.7M | $199M | 13.98% | +0.0% |
| ORBIMED ADVISORS LLC | 3.6M | $109M | 7.64% | −7.6% |
| NEA Management Company, LLC | 3.6M | $108M | 7.59% | +0.0% |
| WELLINGTON MANAGEMENT GROUP LLP | 3.2M | $95M | 6.71% | −4.7% |
| BlackRock, Inc. | 2.9M | $88M | 6.18% | +0.7% |
| FMR LLC | 2.9M | $88M | 6.17% | +18550.3% |
| Deep Track Capital, LP | 2.8M | $82M | 5.79% | −15.1% |
| NVP ASSOCIATES, LLC | 2.1M | $64M | 4.49% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 111.4% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 4,033,554 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.50 | — | — | — |
| 2025-09-30 | 2025-11-06 | −$0.63 | — | — | — |
| 2025-06-30 | 2025-08-07 | −$0.58 | — | — | — |
| 2025-03-31 | 2025-05-12 | −$0.71 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-04 is ESTIMATED from filing cadence (median gap 89d) — not company-confirmed.
